Cargando…

Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

The association between elevated liver enzymes or FIB-4 (fibrosis index 4) and outcome in patients with venous thromboembolism (VTE) has not been evaluated. Data from patients in RIETE (Registro Informatizado Enfermedad TromboEmbólica) were used to assess the association between elevated liver enzym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Urbistondo, Diego, de la Garza, Rocío G., Villares-Fernández, Paula, Font, Carme, Schellong, Sebastian, López-Núñez, Juan José, Gil-Díaz, Aída, del Carmen Díaz-Pedroche, María, Hirmerova, Jana, Monreal, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Im - Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501936/ https://www.ncbi.nlm.nih.gov/pubmed/34626318 http://dx.doi.org/10.1007/s11739-021-02858-x

Ejemplares similares

Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries—the prospective, international, observational WHITE study
por: Palareti, Gualtiero, et al.
Publicado: (2021)

Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
por: López-Núñez, Juan J., et al.
Publicado: (2019)

Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous Thromboembolism
por: Ruiz-Artacho, Pedro, et al.
Publicado: (2018)

COVID-19, coagulopathy and venous thromboembolism: more questions than answers
por: Marietta, Marco, et al.
Publicado: (2020)

Predictors of venous thromboembolism in COVID-19 patients: results of the COVID-19 Brazilian Registry
por: da Silveira, Warley Cezar, et al.
Publicado: (2022)

Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism
por: Ruiz-Artacho, Pedro, et al.
Publicado: (2022)

Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study
por: Squizzato, Alessandro, et al.
Publicado: (2021)

Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia
por: Bevilacqua, Michele, et al.
Publicado: (2023)

Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
por: Faccia, Mariella, et al.
Publicado: (2022)

Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy
por: Melazzini, Federica, et al.
Publicado: (2020)

Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?
por: Camporese, Giuseppe, et al.
Publicado: (2020)

Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism
por: Palareti, Gualtiero, et al.
Publicado: (2020)

Reversal agents for oral anticoagulant-associated major or life-threatening bleeding
por: Moia, Marco, et al.
Publicado: (2019)

Role of age, sex, and specific provoking factors on the distal versus proximal presentation of first symptomatic deep vein thrombosis: analysis of the SWIss Venous ThromboEmbolism Registry (SWIVTER)
por: Spirk, David, et al.
Publicado: (2021)

Liver transplantation in Italy in the era of COVID 19: reorganizing critical care of recipients
por: Siniscalchi, Antonio, et al.
Publicado: (2020)

From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic
por: Vitale, Giovanni, et al.
Publicado: (2021)

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study
por: Palareti, Gualtiero, et al.
Publicado: (2019)

Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy
por: Lenti, Marco Vincenzo, et al.
Publicado: (2020)

Predictors of clinical outcomes of hospitalized patients with Covid-19: focusing on pre-existing liver disease
por: Ferreira, Ana Isabel, et al.
Publicado: (2022)

The vestibular labyrinth is more robust than previously thought—Lessons from surgical removal of intracochlear schwannoma
por: Plontke, Stefan K., et al.
Publicado: (2022)

Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort
por: Licata, Anna, et al.
Publicado: (2021)

Efficacy and safety of direct oral anticoagulants in older adults with atrial fibrillation: a prospective single-centre cohort study
por: Catalani, Filippo, et al.
Publicado: (2023)

Bacterial infections in patients hospitalized with COVID-19
por: Moreno-Torres, Víctor, et al.
Publicado: (2021)

Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago
por: Palareti, Gualtiero, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study
por: Pastori, Daniele, et al.
Publicado: (2021)

Intra-gastric balloon with lifestyle modification: a promising therapeutic option for overweight and obese patients with metabolic dysfunction-associated steatotic liver disease
por: van Dijk, A. M., et al.
Publicado: (2023)

Acute venous thromboembolism in patients with brain cancer: clinical course
por: Becattini, Cecilia, et al.
Publicado: (2023)

Sex Differences in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Blanco-Molina, Angeles, et al.
Publicado: (2014)

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases
por: Poli, Daniela, et al.
Publicado: (2020)

Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism
por: Jara-Palomares, Luis, et al.
Publicado: (2018)

Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry
por: Di Micco, Pierpaolo, et al.
Publicado: (2019)

Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism
por: Moustafa, Farès, et al.
Publicado: (2017)

Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
por: Mahé, Isabelle, et al.
Publicado: (2015)

Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality
por: Violi, Francesco, et al.
Publicado: (2021)

Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels
por: Weinberg, Ido, et al.
Publicado: (2021)

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
por: Testa, Sophie, et al.
Publicado: (2020)

Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Farge, Dominique, et al.
Publicado: (2015)

New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010)

New anticoagulants for the treatment of venous thromboembolism
por: Fernandes, Caio Julio Cesar dos Santos, et al.
Publicado: (2016)

Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8qthe0g415s59aippbr9uubjke